Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacokinetics: Overview01:10

Pharmacokinetics: Overview

9.5K
Pharmacokinetics is a scientific discipline that focuses on the journey of a drug within the body, encompassing four key stages: absorption, distribution, metabolism, and elimination. The first stage, absorption, involves the drug's transfer into the bloodstream. Several factors dictate the extent and speed of this process. For example, the liver often metabolizes oral drugs before they reach systemic circulation, leading to only partial absorption. In contrast, intravenous (IV)...
9.5K
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

2.6K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
2.6K
Toxicokinetics: Overview01:21

Toxicokinetics: Overview

302
Studies that assess how a drug is absorbed, distributed, metabolized, and excreted (ADME) at toxic doses are termed toxicokinetics. Understanding toxicokinetics helps predict adverse drug reactions (ADRs) and manage toxicity in humans.Toxicokinetics differs from pharmacokinetics mainly in the dose levels studied, with toxicokinetics focusing on higher toxic doses. The kinetics at these levels can be non-linear due to altered physiological processes. Toxicodynamics examines the relationship...
302
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

4.6K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
4.6K
Nonlinear Pharmacokinetics: Overview01:19

Nonlinear Pharmacokinetics: Overview

1.4K
Nonlinear or dose-dependent pharmacokinetics is a phenomenon that occurs when the pharmacokinetic parameters of certain drugs deviate from linear pharmacokinetics at higher doses. These drugs do not follow the expected first-order kinetics, where the rate of drug elimination is directly proportional to the drug concentration. Instead, they exhibit a nonlinear relationship, which can be attributed to several factors.
Nonlinearity can arise due to the saturation of plasma protein-binding or...
1.4K
Pharmacodynamics: Overview and Principles01:21

Pharmacodynamics: Overview and Principles

3.8K
Pharmacodynamics is a scientific field that delves into drugs' intricate biochemical, cellular, and physiological effects on the human body. The study of pharmacodynamics helps us understand how drugs interact with the body and elicit various responses.
Most drugs' effects result from their interactions with drug receptors or targets within the body. These interactions trigger specific responses at the cellular or systemic level. Drug receptors can be found on the surfaces of cells or...
3.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Aging and brain free cholesterol concentration on amyloid-β peptide accumulation in guinea pigs.

Biopharmaceutics & drug disposition·2024
Same author

Measuring Amyloid-β Peptide Concentrations in Murine Brain with Improved ELISA Assay.

Current protocols·2021
Same author

Impact of age, hypercholesterolemia, and the vitamin D receptor on brain endogenous β-amyloid peptide accumulation in mice.

Biopharmaceutics & drug disposition·2021
Same author

Human Amyloid-β<sub>40</sub> Kinetics after Intravenous and Intracerebroventricular Injections and Calcitriol Treatment in Rats In Vivo.

Drug metabolism and disposition: the biological fate of chemicals·2020
Same author

Treatment of Porphyromonas gulae infection and downstream pathology in the aged dog by lysine-gingipain inhibitor COR388.

Pharmacology research & perspectives·2020
Same author

Studies To Examine Potential Tolerability Differences between the 5-HT<sub>2C</sub> Receptor Selective Agonists Lorcaserin and CP-809101.

ACS chemical neuroscience·2017

Related Experiment Video

Updated: Apr 24, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

7.3K

Overview of pharmacokinetics.

Lisa D Aimone1, Inés A M de Lannoy2

  • 1Teva Pharmaceuticals, Malvern, Pennsylvania.

Current Protocols in Pharmacology
|September 3, 2014
PubMed
Summary

Understanding drug pharmacokinetics is crucial for effective treatment. This study details methods for administering compounds to rats and collecting samples to determine absorption, distribution, metabolism, and excretion (ADME) profiles.

Keywords:
bioavailabilityblood and tissue collectionhalf-lifein vivo routes of administrationmass balancepharmacokinetics parameters

More Related Videos

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

12.7K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

30.6K

Related Experiment Videos

Last Updated: Apr 24, 2026

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment
08:59

An Intestine/Liver Microphysiological System for Drug Pharmacokinetic and Toxicological Assessment

Published on: December 3, 2020

7.3K
Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
10:44

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures

Published on: March 28, 2017

12.7K
Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs
10:02

Use of Rabbit Eyes in Pharmacokinetic Studies of Intraocular Drugs

Published on: July 23, 2016

30.6K

Area of Science:

  • Pharmacology
  • Drug Development
  • Biomedical Research

Background:

  • Effective drug therapy requires compounds to reach target sites in sufficient concentrations and durations.
  • Compound fate in vivo is governed by absorption, distribution, metabolism, and excretion (ADME) processes.
  • Blood and tissue concentrations reflect the cumulative effect of ADME and target residence time.

Purpose of the Study:

  • To describe protocols for administering compounds to rats via various routes.
  • To outline methods for collecting biological samples for pharmacokinetic analysis.
  • To define fundamental pharmacokinetic terms and illustrate key variables.

Main Methods:

  • Administration of compounds to rats through different routes (e.g., oral, intravenous).
  • Collection of blood, plasma, and tissue samples at specified time points.
  • Analysis of sample concentrations to determine pharmacokinetic parameters.

Main Results:

  • Established protocols for in vivo compound administration in rats.
  • Defined procedures for sample collection to support pharmacokinetic profiling.
  • Provided definitions and examples of key pharmacokinetic terms.

Conclusions:

  • Accurate pharmacokinetic profiling is essential for drug efficacy and safety.
  • Standardized protocols facilitate reproducible ADME studies in preclinical models.
  • Understanding pharmacokinetic principles guides drug design and development.